Recombinant human FBXL13 protein; Source: E. coli derived, PGEX-4T; Tag: GST; Domain: 358-707 aa of BC031285
Conjugate
Unconjugated
Applications
Application Notes
IHC: 1:50-1:500
General Notes
This product (Catalog No. DPABH-24560) is a rabbit-derived polyclonal antibody raised against human FBXL13, targeting the amino acid region 358–707 of the protein. It has been affinity purified by Protein A. FBXL13, a binding determinant of SCF (SKP1-CUL1-F-box)-family E3 ubiquitin ligases, is enriched at centrosomes and interacts with the centrosomal proteins Centrin-2, Centrin-3, CEP152 and CEP192. Induced FBXL13 expression downregulates centrosomal γ-tubulin and disrupts centrosomal microtubule arrays. FBXL13 is a novel regulator of microtubule nucleation activity and participate in promoting cell motility with potential tumour-promoting implications (PMID: 29348145). DPABH-24560 is suitable for use in IHC (1:50–1:500) application. DPABH-24560 is supplied as a liquid formulation in PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
DRC6; Dynein regulatory complex subunit 6; FBL13; F-box and leucine-rich repeat protein 13; F-box/LRR-repeat protein 13
My Review for Rabbit Anti-Human FBXL13 (a.a. 358-707) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.